Pittsburgh draws media attention for innovations in robotics, driverless vehicles and software development. In life sciences, it’s attention from investment dollars supporting breakthroughs in medical devices, therapeutics and health IT.
Ernst & Young reports life sciences companies attracted 27% of regional funding in 2017, a five-year high, equating to 27.2% of total dollars raised.
The PLSG, celebrating 15 years, believes if we invest now, Pittsburgh’s next 15 years of innovations will come from life sciences. A cure for Alzheimer’s, overcoming antibiotic resistance, regenerative medicine: a pipedream on a researcher’s bench? No, it’s all in our commercialization pipeline, right now.
— James F. Jordan, Pittsburgh Life Sciences Greenhouse